Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center



  • Subscribe to our e-Newsletter to receive email updates:

  • Related Articles

    Most Recent


    Join Us

    News: JAK3

    FERM Target for Rare Leukemia

    Friday, November 18th, 2011

    Most patients diagnosed with adult T-cell leukemia/lymphoma (ATLL) – a rare, aggressive blood cancer – will die within a year of diagnosis. No currently available treatments alter the disease’s aggressive clinical course. Utpal Davé, M.D., and colleagues are working to identify genes and pathways that drive or initiate ATLL. In the Oct. 6 issue of […]